Yukari Bando

13PUBLICATIONS
29CO-AUTHORS
Predictive and prognostic markersSurgeryMolecular targetsCancer therapy (excl. chemotherapy and radiation therapy)Medical robotics
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (13)

|Sep 03, 2025
Time to Oligoprogression From the Initiation of the Most Recent Systemic Treatment Is Associated With the Outcome of Progressive Site-Directed Therapy for Castration-Resistant Prostate Cancer.

Naoki Matsuyama, Kotaro Suzuki, Taisuke Tobe

|Sep 03, 2025
Robotic vs. Laparoscopic Adrenalectomy: A Comprehensive Comparison of Surgical Outcomes and Influencing Operative Time.

Yasuyoshi Okamura, Kotaro Suzuki, Yukari Bando

|Jul 04, 2025
Impact of Impaired Renal Function on the Efficacy and Safety of Second-Line Tyrosine Kinase Inhibitor Therapy After First-Line Immuno-Oncology Combination Therapy in Metastatic Renal Cell Carcinoma: A Japanese Multicenter Retrospective Study.

Naoki Fujita, Yuto Matsushita, Takahiro Kojima

|Apr 07, 2025
Prognostic Impact of the Maximal Evaluable Lesion Size in Patients With Metastatic Renal Cell Carcinoma Treated With Nivolumab Plus Ipilimumab Combination Therapy.

Yoshie Mita, Jun Teishima, Takuto Hara

|Oct 14, 2024
Choosing the optimal therapy for metastatic renal cell carcinoma: Insights from a real-world comparative study.

Takuto Hara, Jun Teishima, Yasuyoshi Okamura

|Oct 01, 2024
Effects of modifying hinotori™ surgical robot system on perioperative outcome of robot-assisted radical prostatectomy.

Jun Teishima, Naoto Wakita, Yukari Bando

Pageof 3

Frequent Collaborators

10 joint publications

Tomoaki Terakawa

9 joint publications

Takuto Hara

6 joint publications

Kotaro Suzuki

4 joint publications

Yasuyoshi Okamura